Literature DB >> 18460607

Cellular energetic status supervises the synthesis of bis-diphosphoinositol tetrakisphosphate independently of AMP-activated protein kinase.

Kuicheon Choi1, Elahe Mollapour, Jae H Choi, Stephen B Shears.   

Abstract

Cells aggressively defend adenosine nucleotide homeostasis; intracellular biosensors detect variations in energetic status and communicate with other cellular networks to initiate adaptive responses. Here, we demonstrate some new elements of this communication process, and we show that this networking is compromised by off-target, bioenergetic effects of some popular pharmacological tools. Treatment of cells with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), so as to simulate elevated AMP levels, reduced the synthesis of bis-diphosphoinositol tetrakisphosphate ([PP](2)-InsP(4)), an intracellular signal that phosphorylates proteins in a kinase-independent reaction. This was a selective effect; levels of other inositol phosphates were unaffected by AICAR. By genetically manipulating cellular AMP-activated protein kinase activity, we showed that it did not mediate these effects of AICAR. Instead, we conclude that the simulation of deteriorating adenosine nucleotide balance itself inhibited [PP](2)-InsP(4) synthesis. This conclusion is consistent with our demonstrating that oligomycin elevated cellular [AMP] and selectively inhibited [PP](2)-InsP(4) synthesis without affecting other inositol phosphates. In addition, we report that the shortterm increases in [PP](2)-InsP(4) levels normally seen during hyperosmotic stress were attenuated by 2-(2-chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluoro-benzamide (PD184352). The latter is typically considered an exquisitely specific mitogen-activated protein kinase kinase (MEK) inhibitor, but small interfering RNA against MEK or extracellular signal-regulated kinase revealed that this mitogen-activated protein kinase pathway was not involved. Instead, we demonstrate that [PP](2)-InsP(4) synthesis was inhibited by PD184352 through its nonspecific effects on cellular energy balance. Two other MEK inhibitors, 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) and 2'-amino-3'-methoxyflavone (PD98059), had similar off-target effects. We conclude that the levels and hence the signaling strength of [PP](2)-InsP(4) is supervised by cellular adenosine nucleotide balance, signifying a new link between signaling and bioenergetic networks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460607      PMCID: PMC2632961          DOI: 10.1124/mol.107.044628

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

Review 1.  AMP-activated protein kinase: the energy charge hypothesis revisited.

Authors:  D G Hardie; S A Hawley
Journal:  Bioessays       Date:  2001-12       Impact factor: 4.345

2.  The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

Authors:  Lee G D Fryer; Asha Parbu-Patel; David Carling
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

3.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.

Authors:  A S Marsin; L Bertrand; M H Rider; J Deprez; C Beauloye; M F Vincent; G Van den Berghe; D Carling; L Hue
Journal:  Curr Biol       Date:  2000-10-19       Impact factor: 10.834

4.  TSC2 mediates cellular energy response to control cell growth and survival.

Authors:  Ken Inoki; Tianqing Zhu; Kun-Liang Guan
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

5.  Signaling by higher inositol polyphosphates. Synthesis of bisdiphosphoinositol tetrakisphosphate ("InsP8") is selectively activated by hyperosmotic stress.

Authors:  Xavier Pesesse; Kuicheon Choi; Tong Zhang; Stephen B Shears
Journal:  J Biol Chem       Date:  2004-08-16       Impact factor: 5.157

6.  Aggravation of necrotic death of glucose-deprived cells by the MEK1 inhibitors U0126 and PD184161 through depletion of ATP.

Authors:  Hong Wa Yung; Andreas Wyttenbach; Aviva M Tolkovsky
Journal:  Biochem Pharmacol       Date:  2004-07-15       Impact factor: 5.858

7.  Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis In 3T3-L1 adipocytes.

Authors:  Wu Yin; James Mu; Morris J Birnbaum
Journal:  J Biol Chem       Date:  2003-08-25       Impact factor: 5.157

8.  Inositol pyrophosphates mediate chemotaxis in Dictyostelium via pleckstrin homology domain-PtdIns(3,4,5)P3 interactions.

Authors:  Hongbo R Luo; Yi Elaine Huang; Jianmeng C Chen; Adolfo Saiardi; Miho Iijima; Keqiang Ye; Yunfei Huang; Eiichiro Nagata; Peter Devreotes; Solomon H Snyder
Journal:  Cell       Date:  2003-09-05       Impact factor: 41.582

9.  Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling.

Authors:  Joost J F P Luiken; Susan L M Coort; Jodil Willems; Will A Coumans; Arend Bonen; Ger J van der Vusse; Jan F C Glatz
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

10.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

View more
  28 in total

1.  Asp1 from Schizosaccharomyces pombe binds a [2Fe-2S](2+) cluster which inhibits inositol pyrophosphate 1-phosphatase activity.

Authors:  Huanchen Wang; Vasudha S Nair; Ashley A Holland; Samanta Capolicchio; Henning J Jessen; Michael K Johnson; Stephen B Shears
Journal:  Biochemistry       Date:  2015-10-09       Impact factor: 3.162

Review 2.  Diphosphoinositol polyphosphates: what are the mechanisms?

Authors:  Stephen B Shears; Nikhil A Gokhale; Huanchen Wang; Angelika Zaremba
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 3.  The inositol pyrophosphate pathway in health and diseases.

Authors:  Anutosh Chakraborty
Journal:  Biol Rev Camb Philos Soc       Date:  2017-12-27

4.  Synthesis of densely phosphorylated bis-1,5-diphospho-myo-inositol tetrakisphosphate and its enantiomer by bidirectional P-anhydride formation.

Authors:  Samanta Capolicchio; Huanchen Wang; Divyeshsinh T Thakor; Stephen B Shears; Henning J Jessen
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-14       Impact factor: 15.336

Review 5.  Inositol pyrophosphates: why so many phosphates?

Authors:  Stephen B Shears
Journal:  Adv Biol Regul       Date:  2014-10-05

Review 6.  Inositol pyrophosphates as mammalian cell signals.

Authors:  Anutosh Chakraborty; Seyun Kim; Solomon H Snyder
Journal:  Sci Signal       Date:  2011-08-23       Impact factor: 8.192

7.  Inositol Hexakisphosphate Kinase 1 (IP6K1) Regulates Inositol Synthesis in Mammalian Cells.

Authors:  Wenxi Yu; Cunqi Ye; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2016-03-07       Impact factor: 5.157

8.  Control of XPR1-dependent cellular phosphate efflux by InsP8 is an exemplar for functionally-exclusive inositol pyrophosphate signaling.

Authors:  Xingyao Li; Chunfang Gu; Sarah Hostachy; Soumyadip Sahu; Christopher Wittwer; Henning J Jessen; Dorothea Fiedler; Huanchen Wang; Stephen B Shears
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

Review 9.  The emerging roles of inositol pyrophosphates in eukaryotic cell physiology.

Authors:  Swarna Gowri Thota; Rashna Bhandari
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

Review 10.  Structural insight into inositol pyrophosphate turnover.

Authors:  Stephen B Shears; Jeremy D Weaver; Huanchen Wang
Journal:  Adv Biol Regul       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.